HIVE Blockchain Technologies Ltd. (CVE:HIV) Given Average Recommendation of “Strong Buy” by Analysts

Shares of HIVE Blockchain Technologies Ltd. (CVE:HIVGet Free Report) have earned a consensus rating of “Strong Buy” from the five brokerages that are covering the firm, MarketBeat.com reports. Five analysts have rated the stock with a strong buy recommendation.

A number of research analysts have issued reports on HIV shares. Keefe, Bruyette & Woods raised shares of HIVE Blockchain Technologies to a “moderate buy” rating in a report on Wednesday, January 8th. Rosenblatt Securities raised shares of HIVE Blockchain Technologies to a “strong-buy” rating in a research note on Friday, March 7th. Finally, Roth Capital raised shares of HIVE Blockchain Technologies to a “strong-buy” rating in a research note on Wednesday, December 18th.

Check Out Our Latest Research Report on HIV

HIVE Blockchain Technologies Stock Performance

HIVE Blockchain Technologies Ltd. is a services company in the Business Services industry.

Further Reading

Analyst Recommendations for HIVE Blockchain Technologies (CVE:HIV)

Receive News & Ratings for HIVE Blockchain Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HIVE Blockchain Technologies and related companies with MarketBeat.com's FREE daily email newsletter.